PLYMOUTH MEETING, Pa. (AP) _ Inovio Pharmaceuticals Inc. (INO) on Monday reported a loss of $32.5 million in its first quarter.
On a per-share basis, the Plymouth Meeting, Pennsylvania-based company said it had a loss of 26 cents.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.
The drugmaker posted revenue of $1.3 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $1.5 million.
Inovio shares have more than tripled since the beginning of the year. In the final minutes of trading on Monday, shares hit $12.03, more than tripling in the last 12 months.